Charles Schwab shares declined nearly 3% following a price target reduction from Morgan Stanley. Despite the lower valuation, the investment bank maintained its overweight rating on the brokerage giant.
- Price target reduced by $13 per share
- New fair value estimate set at $135
- Profitability forecasts trail consensus by 4-5% for 2026/2027
- Stock experienced a nearly 3% intraday decline
- Analyst maintains a bullish 'overweight' recommendation
Sign up free to read the full analysis
Create a free account to unlock full AI-curated market articles, personalized alerts, and more.